Market Indices


Latest News

Raymond James analyst issues STRONG BUY recommendation for MIST on...

April 10, 2026   MIST -0.53%

Raymond James analyst issues STRONG BUY recommendation for PRAX on...

April 10, 2026   PRAX -1.69%

Citigroup analyst issues OUTPERFORM recommendation for DAVE on April 10,...

April 10, 2026   DAVE 0.05%

Bobby Brooks from Northland Securities issued a price target of $14.00...

April 10, 2026   RELL -7.59%

from Canaccord Genuity issued a price target of $22.00 for...

April 10, 2026   SPIR 18.08%


Price Targets

Bobby Brooks from Northland Securities issued a price target of $14.00 for RELL on 2026-04-10 13:04:20.The adjusted price target was set to $14.00.At the time of the announcement,

April 10, 2026   RELL -7.59%

from Canaccord Genuity issued a price target of $22.00 for SPIR on 2026-04-10 11:05:34.The adjusted price target was set to $22.00.At the time of the announcement, SPIR...

April 10, 2026   SPIR 18.08%

Roger Song from Jefferies issued a price target of $16.00 for CTMX on 2026-03-18 14:16:00.The adjusted price target was set to $16.00.At the time of the announcement, CTMX...

March 18, 2026   CTMX 3.89%

Stephen Willey from Stifel Nicolaus issued a price target of $17.00 for ABEO on 2026-03-17 19:53:00.The adjusted price target was set to $17.00.At the time of the announcement,

March 17, 2026   ABEO -4.78%

Michael Baker from D.A. Davidson issued a price target of $68.00 for CTRN on 2026-03-17 19:35:00.The adjusted price target was set to $68.00.At the time of the announcement,

March 17, 2026   CTRN -1.39%



Market Movers

Top Gainers (%)
AONC
American Oncology Network
10.99
57.00%
CUE
Cue Biopharma, Inc.
0.45
54.42%
MAPSW
WM Technology Inc
0.00
48.48%
QSIAW
Quantum-Si incorporated
0.11
40.99%
MAXN
Maxeon Solar Technologies
1.78
34.86%
TPST
Tempest Therapeutics, Inc
2.06
30.06%
SCLXW
SCLXW
0.09
22.22%
SPIR
Spire Global, Inc.
21.16
18.08%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP -0.67%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE -5.46%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK -0.73%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN -0.70%